Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Collaboration revenue $ 82,538 $ 0
Operating expenses:    
Research and development 697,276 179,426
Selling, general and administrative 115,925 38,693
Total operating expenses 813,201 218,119
Loss from operations (730,663) (218,119)
Other income (expense):    
Interest and other income 525 3,717
Change in fair value of derivative liabilities (20,116) 0
Transaction costs (4,516) 0
Other expense (5,184) (45)
Total loss from operations before income taxes (759,954) (214,447)
Income tax expense (benefit) (4,501) 2
Net loss $ (755,453) $ (214,449)
Basic net loss per share (in usd per share) $ (1.22) $ (0.79)
Diluted net loss per share (in usd per share) $ (1.22) $ (0.79)
Basic weighted-average shares outstanding (in shares) 620,816,420 270,940,197
Diluted weighted-average shares outstanding (in shares) 620,816,420 270,940,197